Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 29;6(9):2481-2485.
doi: 10.1016/j.ekir.2021.06.013. eCollection 2021 Sep.

Clinical Outcomes of People With Fabry Disease - ANZDATA Registry Study

Affiliations

Clinical Outcomes of People With Fabry Disease - ANZDATA Registry Study

Monica S Ng et al. Kidney Int Rep. .

Erratum in

No abstract available

Keywords: Fabry disease; clinical outcomes; end-stage kidney disease; enzyme replacement therapy; kidney replacement therapy; kidney transplantation; patient outcomes; registries; risk factors; survival.

PubMed Disclaimer

References

    1. Waldek S., Patel M.R., Banikazemi M. Life expectancy and cause of death in males and females with Fabry disease: findings from the Fabry Registry. Genet Med. 2009;11:790–796. - PubMed
    1. Lidove O., West M.L., Pintos-Morell G. Effects of enzyme replacement therapy in Fabry disease—a comprehensive review of the medical literature. Gen Med. 2010;12:668–679. - PubMed
    1. Mignani R., Feriozzi S., Pisani A. Agalsidase therapy in patients with Fabry disease on renal replacement therapy: a nationwide study in Italy. Nephrol Dial Transplant. 2007;23:1628–1635. - PubMed
    1. Cybulla M., Walter K.N., Schwarting A. Kidney transplantation in patients with Fabry disease. Transpl Int. 2009;22:475–481. - PubMed
    1. Thadhani R., Wolf M., West M.L. Patients with Fabry disease on dialysis in the United States. Kidney Int. 2002;61:249–255. - PubMed

LinkOut - more resources